Literature DB >> 20347482

Co-trimoxazole, cART, and non-AIDS infectious diseases.

Xavier Anglaret1, Serge Eholie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347482     DOI: 10.1016/S0140-6736(10)60200-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.

Authors:  Olivier Marcy; Didier Laureillard; Yoann Madec; Sarin Chan; Charles Mayaud; Laurence Borand; Narom Prak; Chindamony Kim; Kim Khemarin Lak; Chanroeurn Hak; Bunnet Dim; Thim Sok; Jean-François Delfraissy; Anne E Goldfeld; François-Xavier Blanc
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

Review 2.  Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.

Authors:  Christine Manyando; Eric M Njunju; Umberto D'Alessandro; Jean-Pierre Van Geertruyden
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.